Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)

Aim: To examine the efficacy and safety of prasugrel vs clopidogrel in thrombotic stroke patients at risk of ischemic stroke.Methods: This multicenter, active-controlled, randomized, double-blind, double-dummy, parallel group study enrolled thrombotic stroke patients aged ≥ 50 years at risk of ische...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Atherosclerosis and Thrombosis 2023/03/01, Vol.30(3), pp.222-236
Hauptverfasser:	Kitazono, Takanari, Kamouchi, Masahiro, Matsumaru, Yuji, Nakamura, Masato, Umemura, Kazuo, Matsuo, Hajime, Koyama, Nobuyuki, Tsutsumi, Junko, Kimura, Kazumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Clopidogrel Clopidogrel - adverse effects Hemorrhage - chemically induced Humans Ischemic Stroke - drug therapy Myocardial Infarction - epidemiology Original Phase III Platelet Aggregation Inhibitors - adverse effects Prasugrel Prasugrel Hydrochloride - adverse effects Risk Factors Stroke - epidemiology Thrombotic stroke Thrombotic Stroke - chemically induced Thrombotic Stroke - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!